LOTI yields 0.96% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, LOTI + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LOTI + PFE for your $10,000?
LOTI blends US large-cap dividend-paying equities with tactical allocations to fixed income. Equity holdings center on companies the Adviser deems recession resistant, meaning businesses with stable demand, recurring revenue models, and lower sensitivity to economic cycles. They are typically characterized by consistent dividend growth, visibility in earnings, and strong cash flow stability, reinforced by low demand elasticity and high switching costs. Equities are often equally weighted, though allocations may shift with market conditions. The fund complements this equity base with fixed income exposure primarily through ETFs and bond funds invested in corporate and government securities. Credit quality and duration are actively adjusted, with up to 20% of assets available for high yield bonds. This dual structure provides flexibility to navigate different market environments, seeking to generate income while managing risks across both equity and bond allocations.
Full LOTI Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.